

#145: Selective Safety Data Collection: As a Tool to Advance Clinical Trial Designs
Monday, June 17, 2024 3:30 PM to 4:30 PM · 1 hr. (US/Pacific)
Room 5AB
01: ClinSafety-PV
Information
This session is focused on sharing experience with E19 implementation from multiple stakeholders to identify successes and challenges.
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
ICH
Speakers
FS
Fannie St-Gelais
Manager, Health Product and Food BranchHealth Canada
Anastasia Lesogor
Senior Global Program Clinical Program HeadNovartis Pharma AG
Kevin Bugin
Head of Global Regulatory Policy and IntelligenceAmgen
Mary Thanh Hai
Deputy Director for Clinical, OND, CDERFDAEC
Eileen Craig
Clinical Lead , DDLO, OCHEN, OND, CDERFDA

